Sitryx Therapeutics
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $67M
Investors
- 6
About Sitryx Therapeutics
Founded in 2018, Sitryx Therapeutics Limited operates from its headquarters in Oxford, UK. The company specializes in immunometabolism, targeting specific metabolic pathways in immune cells. Paul Tak, the founder, has a history of involvement in the biopharmaceutical sector.Sitryx focuses on developing disease-modifying therapies aimed at correcting immune cell dysfunction. Their key product, SIT-047, is a novel oral MTHFD2 inhibitor, currently nominated for clinical development in psoriatic arthritis, with trials expected to advance by May 2025.1 bn, which includes development milestones and tiered royalties. The company aims to launch SIT-047 and expand its presence in new markets, specifically targeting regions in North America and Europe for future commercialization of its therapies.
Who invested in Sitryx Therapeutics
6 investors across 2 rounds
See all investors in Sitryx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sitryx Therapeutics
Who invested in Sitryx Therapeutics?
Sitryx Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sitryx Therapeutics raised?
Sitryx Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sitryx Therapeutics last raise money?
Sitryx Therapeutics's most recent round on record is a Series A, in Sep 2023.
What does Sitryx Therapeutics do?
Founded in 2018, Sitryx Therapeutics Limited operates from its headquarters in Oxford, UK.
Where is Sitryx Therapeutics headquartered?
Sitryx Therapeutics is headquartered in Oxford, UK.
Which VCs invest in companies like Sitryx Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Sitryx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sitryx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.